Cargando…
Binding and Avidity Signatures of Polyclonal Sera From Individuals With Different Exposure Histories to Severe Acute Respiratory Syndrome Coronavirus 2 Infection, Vaccination, and Omicron Breakthrough Infections
BACKGROUND: The number of exposures to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and to vaccine antigens affect the magnitude and avidity of the polyclonal response. METHODS: We studied binding and avidity of different antibody isotypes to the spike, the receptor-binding domain (R...
Autores principales: | Singh, Gagandeep, Abbad, Anass, Tcheou, Johnstone, Mendu, Demodara Rao, Firpo-Betancourt, Adolfo, Gleason, Charles, Srivastava, Komal, Cordon-Cardo, Carlos, Simon, Viviana, Krammer, Florian, Carreño, Juan Manuel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10469125/ https://www.ncbi.nlm.nih.gov/pubmed/37104046 http://dx.doi.org/10.1093/infdis/jiad116 |
Ejemplares similares
-
mRNA-1273 but not BNT162b2 induces antibodies against polyethylene glycol (PEG) contained in mRNA-based vaccine formulations
por: Carreño, Juan Manuel, et al.
Publicado: (2022) -
A tool for evaluating heterogeneity in avidity of polyclonal antibodies
por: Li, Kan, et al.
Publicado: (2023) -
SARS-CoV-2 vaccination induces mucosal antibody responses in previously infected individuals
por: Sano, Kaori, et al.
Publicado: (2022) -
Creating surveillance data infrastructure using laboratory analytics: Leveraging visiun and epic systems to support COVID-19 pandemic response
por: Haghighi, Mehrvash, et al.
Publicado: (2022) -
Comprehensive profiling of neutralizing polyclonal sera targeting coxsackievirus B3
por: Álvarez-Rodríguez, Beatriz, et al.
Publicado: (2023)